129 related articles for article (PubMed ID: 192805)
1. Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphate.
Kern ER; Richards JT; Overall JC; Glasgow LA
J Infect Dis; 1977 Apr; 135(4):557-67. PubMed ID: 192805
[TBL] [Abstract][Full Text] [Related]
2. Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid.
Kern ER; Richards JT; Overall JC; Glasgow LA
Antimicrob Agents Chemother; 1978 Jan; 13(1):53-60. PubMed ID: 204250
[TBL] [Abstract][Full Text] [Related]
3. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.
Klein RJ; Friedman-Kien AE; Yellin PB
Infect Immun; 1978 Apr; 20(1):130-5. PubMed ID: 208970
[TBL] [Abstract][Full Text] [Related]
4. Experimental herpes simplex virus encephalitis: Comparative effects of treatment with cytosine arabinoside and adenine arabinoside.
Griffith JF; Fitzwilliam JF; Casagrande S; Butler SR
J Infect Dis; 1975 Nov; 132(5):506-10. PubMed ID: 171318
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antiviral effects of adenine arabinoside and humoral antibodies in experimental encephalitis due to Herpesvirus hominis.
Cho CT; Feng KK; Brahmacupta N
J Infect Dis; 1976 Feb; 133(2):157-67. PubMed ID: 173763
[TBL] [Abstract][Full Text] [Related]
6. Derivative of adenine arabinoside in experimental herpes encephalitis.
Adams DH; Cameron KR
Lancet; 1977 Oct; 2(8041):760. PubMed ID: 71559
[No Abstract] [Full Text] [Related]
7. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
Kern ER; Richards JT; Overall JC; Glasgow LA
Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
[TBL] [Abstract][Full Text] [Related]
8. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs.
Richards JT; Kern ER; Overall JC; Glasgow LA
Antiviral Res; 1982 May; 2(1-2):27-39. PubMed ID: 6179469
[TBL] [Abstract][Full Text] [Related]
9. Genital herpetic infection in men and women: clinical course and effect of topical application of adenine arabinoside.
Adams HG; Benson EA; Alexander ER; Vontver LA; Remington MA; Holmes KK
J Infect Dis; 1976 Jun; 133 Suppl():A151-9. PubMed ID: 180196
[TBL] [Abstract][Full Text] [Related]
10. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study.
Whitley RJ; Soong SJ; Dolin R; Galasso GJ; Ch'ien LT; Alford CA
N Engl J Med; 1977 Aug; 297(6):289-94. PubMed ID: 195208
[TBL] [Abstract][Full Text] [Related]
11. The activity of iododeoxyuridine, adenine arabinoside, cytosine arabinoside, ribavirin and phosphonoacetic acid against herpes virus in the hairless mouse model.
Harris SR; Boyd MR
J Antimicrob Chemother; 1977 Mar; 3 Suppl A():91-8. PubMed ID: 193825
[No Abstract] [Full Text] [Related]
12. Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
Alenius S
Arch Virol; 1980; 65(2):149-56. PubMed ID: 6252867
[TBL] [Abstract][Full Text] [Related]
13. Anti-herpes activity of adenine arabinoside monophosphate.
Trobe JD; Centifanto Y; Zam ZS; Varnell E; Kaufman HE
Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of antiviral agents and humoral antibodies in experimental Herpesvirus hominis encephalitis.
Cho CT; Feng KK
Ann N Y Acad Sci; 1977 Mar; 284():321-34. PubMed ID: 280140
[TBL] [Abstract][Full Text] [Related]
15. Interaction of adenine arabinoside and host defense factors in experimental infections due to Herpesvirus hominis.
Cho CT; Feng KK
J Infect Dis; 1977 Mar; 135(3):468-72. PubMed ID: 191543
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir treatment of disseminated herpes simplex virus type 2 infection in weanling mice: alteration of mortality and pathogenesis.
Kern ER; Richards JT; Overall JC
Antiviral Res; 1986 Jul; 6(4):189-95. PubMed ID: 2427021
[TBL] [Abstract][Full Text] [Related]
17. [The virostatic effect of adenine-arabinoside monophosphate. Experimental findings and preliminary clinical experiences].
Werner GT; Bömer H; Metzger E; Sauer O; Schneider H; Schubert E; Treuner J
Fortschr Med; 1978 Aug; 96(32):1589-97. PubMed ID: 680620
[TBL] [Abstract][Full Text] [Related]
18. Effective antiviral chemotherapy in cytomegalovirus infection of mice.
Overall JC; Kern ER; Glasgow LA
J Infect Dis; 1976 Jun; 133 Suppl():A237-44. PubMed ID: 180206
[TBL] [Abstract][Full Text] [Related]
19. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
[TBL] [Abstract][Full Text] [Related]
20. Intranasal challenge of mice with herpes simplex virus: an experimental model for evaluation of the efficacy of antiviral drugs.
De Clercq E; Luczak M
J Infect Dis; 1976 Jun; 133 Suppl():A226-36. PubMed ID: 180205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
